PAH patients with cardiovascular disease risk had similar hospitalization and mortality rates as those without after a ...

Columnist Colleen Steele says that glimmers are like an antidote to some of the events that spark her caregiving anxiety.

Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with PAH has completed enrollment.

Columnist Anna Jeter is delighted to find themes that are relevant to her life in the fictional narratives of writers and ...

Adding Winrevair treatment significantly reduced the risk of clinical worsening in people with a recent PAH diagnosis, per a ...

With patient enrollment now complete, topline results are expected early next year from a Phase 3 trial testing PAH treatment ...

Streamlining collaboration with FDA “We’re excited to be included in the TAP Pilot as the program will help streamline collaboration with FDA — from initiating our pivotal clinical study to ...

“These data represent the most comprehensive long-term safety, tolerability, and survival data for [Uptravi], and provide the longest follow-up period published to date for a PAH therapy,” the ...

Heart rhythm, pressure measured More than half of the patients (57.4%) were women, and 2,503 (15.6%) had atrial fibrillation — an irregular heartbeat — while the rest had a normal heart rhythm. Nearly ...